To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06281678
Title A Study of IBI363 in Subjects With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco (UCSF) RECRUITING San Francisco California 94143 United States Details
Ocala Oncology Center RECRUITING Ocala Florida 34474 United States Details
BRCR Medical Center RECRUITING Plantation Florida 33322 United States Details
University of Kansas Medical Center (KUMC) RECRUITING Fairway Kansas 66205 United States Details
Michigan Hematology & Oncology Consultants - MedOnc Dearborn RECRUITING Dearborn Michigan 48126 United States Details
Michigan Hematology & Oncology Consultants - MedOnc Troy RECRUITING Troy Michigan 48098 United States Details
MD Anderson Cancer Center-University of Texas RECRUITING Houston Texas 77025 United States Details
Oncology Consultants P.A. RECRUITING Houston Texas 77030 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field